Aceto Stock Price, News & Analysis (NASDAQ:ACET)

$7.54 +0.33 (+4.58 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$7.54
Today's Range$7.27 - $7.54
52-Week Range$6.99 - $17.10
Volume285,750 shs
Average Volume834,649 shs
Market Capitalization$221.80 million
P/E Ratio-47.13
Dividend Yield3.61%
Beta1.4

About Aceto (NASDAQ:ACET)

Aceto logoAceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company's business is organized along product lines into three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. As of June 30, 2016, it distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the agricultural, coatings and industrial chemical industries. The Human Health segment includes finished dosage form generic drugs and nutraceutical products. As of June 30, 2016, the Pharmaceutical Ingredients segment had two product groups: Active Pharmaceutical Ingredients and Pharmaceutical Intermediates. The Performance Chemicals segment includes specialty chemicals and agricultural protection products.

Receive ACET News and Ratings via Email

Sign-up to receive the latest news and ratings for ACET and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceuticals
Sub-IndustryTrading Companies & Distributors
SectorMedical
SymbolNASDAQ:ACET
CUSIP00444610
Phone516-627-6000

Debt

Debt-to-Equity Ratio0.79%
Current Ratio2.00%
Quick Ratio1.38%

Price-To-Earnings

Trailing P/E Ratio-47.125
Forward P/E Ratio7.39
P/E Growth0.71

Sales & Book Value

Annual Sales$638.32 million
Price / Sales0.36
Cash Flow$2.55 per share
Price / Cash2.96
Book Value$12.91 per share
Price / Book0.58

Profitability

Trailing EPS($0.16)
Net Income$11.37 million
Net Margins-0.79%
Return on Equity10.26%
Return on Assets4.01%

Miscellaneous

Employees286
Outstanding Shares30,760,000

Aceto (NASDAQ:ACET) Frequently Asked Questions

What is Aceto's stock symbol?

Aceto trades on the NASDAQ under the ticker symbol "ACET."

How often does Aceto pay dividends? What is the dividend yield for Aceto?

Aceto declared a quarterly dividend on Thursday, February 1st. Shareholders of record on Friday, March 9th will be paid a dividend of $0.065 per share on Friday, March 23rd. This represents a $0.26 dividend on an annualized basis and a yield of 3.45%. The ex-dividend date is Thursday, March 8th. View Aceto's Dividend History.

How were Aceto's earnings last quarter?

Aceto Co. (NASDAQ:ACET) announced its quarterly earnings results on Thursday, February, 1st. The company reported $0.22 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.23 by $0.01. The business had revenue of $171.20 million for the quarter, compared to analysts' expectations of $176.50 million. Aceto had a positive return on equity of 10.26% and a negative net margin of 0.79%. The firm's quarterly revenue was up 36.3% on a year-over-year basis. During the same quarter last year, the business posted $0.24 earnings per share. View Aceto's Earnings History.

When will Aceto make its next earnings announcement?

Aceto is scheduled to release their next quarterly earnings announcement on Thursday, May, 3rd 2018. View Earnings Estimates for Aceto.

What guidance has Aceto issued on next quarter's earnings?

Aceto updated its FY18 earnings guidance on Thursday, February, 1st. The company provided EPS guidance of $1.00-1.05 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.07. The company issued revenue guidance of +10-15% to ~701.8-733.7 million, compared to the consensus revenue estimate of $734.29 million.

Where is Aceto's stock going? Where will Aceto's stock price be in 2018?

1 equities research analysts have issued 12-month price objectives for Aceto's stock. Their forecasts range from $10.00 to $10.00. On average, they anticipate Aceto's stock price to reach $10.00 in the next twelve months. View Analyst Ratings for Aceto.

What are Wall Street analysts saying about Aceto stock?

Here are some recent quotes from research analysts about Aceto stock:

  • 1. Canaccord Genuity analysts commented, "We are pleased with the appointment of Ed Borkowski as chief financial officer, as he brings a breadth of generics knowledge and experience that will likely help Aceto’s continued transition into a human health company. We like the turnaround potential for Aceto, but believe management will need to execute for a number of quarters before generating meaningful investor interest; we maintain our BUY rating on ACET shares. Roth’s retirement has been well telegraphed in parallel to the on-boarding of William Kennally as CEO. Douglas Roth has been CFO since 2001, and was a key leader in the transformation of Aceto from specialty chemicals/API to human health. After the appointment of Bill Kennally as CEO late last year, we expected Aceto to find a thoughtful, seasoned finance leader to complement Kennally’s experience, and see Borkowski as an excellent add." (2/16/2018)
  • 2. According to Zacks Investment Research, "Aceto Corporation markets, sells and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products and specialty chemicals. The company's operating segment consists of Human Health, Pharmaceutical Ingredients and Performance Chemicals. Human Health segment supplies raw materials used in the production of nutritional and packaged dietary supplements. It markets and distributes its generic prescription and over the counter pharmaceutical products. Pharmaceutical Ingredients segment offers active pharmaceutical ingredients and pharmaceutical intermediates. Performance Chemicals segment provides specialty chemicals. It serves chemical, agricultural, human health and pharmaceutical industries. The company operates primarily in United States, Europe, and Asia. Aceto Corporation and is headquartered in Port Washington, New York. " (2/6/2018)

Who are some of Aceto's key competitors?

Who are Aceto's key executives?

Aceto's management team includes the folowing people:

  • Albert L. Eilender, Chairman of the Board (Age 73)
  • William C. Kennally III, President, Chief Executive Officer, Director (Age 61)
  • Douglas A. Roth, Chief Financial Officer, Senior Vice President (Age 59)
  • Edward J. Borkowski CPA, Chief Financial Officer (Age 59)
  • Walter J. Kaczmarek III, Chief Operating Officer (Age 57)
  • Charles J. Alaimo, Senior Vice President - Human Resources (Age 50)
  • Steven Rogers, Senior Vice President, Chief Legal Officer and Secretary (Age 55)
  • Raymond Bartone, Senior Vice President - Nutritionals (Age 54)
  • Frank V. DeBenedittis, Senior Vice President - Corporate Business Development (Age 61)
  • Terry Kippley, Senior Vice President - Agricultural Protection Products (Age 52)

Who owns Aceto stock?

Aceto's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (13.13%), Royce & Associates LP (3.61%), Deutsche Bank AG (1.20%), Millennium Management LLC (1.19%), Two Sigma Investments LP (1.12%) and Two Sigma Advisers LP (0.87%). Company insiders that own Aceto stock include Albert L Eilender, Charles John Alaimo, Daniel B Yarosh, Douglas A Roth, Frances P Scally, Frank Debenedittis, Hans C Noetzli, Nicolas I Shackley, Raymond Bartone, Salvatore J Sr Guccione Sr, Satish Srinivasan, Steven Rogers, Terry Kippley, Walter J Kaczmarek III and William N Britton. View Institutional Ownership Trends for Aceto.

Who sold Aceto stock? Who is selling Aceto stock?

Aceto's stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Citadel Advisors LLC, Alambic Investment Management L.P., Engineers Gate Manager LP, Renaissance Technologies LLC, Deutsche Bank AG and Perritt Capital Management Inc.. Company insiders that have sold Aceto company stock in the last year include Albert L Eilender, Charles John Alaimo, Douglas A Roth, Frances P Scally, Frank Debenedittis, Salvatore J Sr Guccione Sr, Steven Rogers and Walter J Kaczmarek III. View Insider Buying and Selling for Aceto.

Who bought Aceto stock? Who is buying Aceto stock?

Aceto's stock was purchased by a variety of institutional investors in the last quarter, including Two Sigma Investments LP, Guggenheim Capital LLC, BlackRock Inc., Royce & Associates LP, Goldman Sachs Group Inc., Two Sigma Advisers LP, Municipal Employees Retirement System of Michigan and LSV Asset Management. View Insider Buying and Selling for Aceto.

How do I buy Aceto stock?

Shares of Aceto can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aceto's stock price today?

One share of Aceto stock can currently be purchased for approximately $7.54.

How big of a company is Aceto?

Aceto has a market capitalization of $221.80 million and generates $638.32 million in revenue each year. The company earns $11.37 million in net income (profit) each year or ($0.16) on an earnings per share basis. Aceto employs 286 workers across the globe.

How can I contact Aceto?

Aceto's mailing address is 4 TRI HARBOR COURT, PORT WASHINGTON NY, 11050. The company can be reached via phone at 516-627-6000 or via email at [email protected]


MarketBeat Community Rating for Aceto (ACET)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  117 (Vote Outperform)
Underperform Votes:  130 (Vote Underperform)
Total Votes:  247
MarketBeat's community ratings are surveys of what our community members think about Aceto and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Aceto (NASDAQ:ACET) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyHoldHoldHold
Consensus Rating Score: 3.002.332.332.33
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $10.00$15.00$15.00$18.00
Price Target Upside: 38.12% upside51.98% upside51.98% upside58.87% upside

Aceto (NASDAQ:ACET) Consensus Price Target History

Price Target History for Aceto (NASDAQ:ACET)

Aceto (NASDAQ:ACET) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/16/2018Canaccord GenuitySet Price TargetBuy$10.00MediumView Rating Details
2/3/2017Craig HallumDowngradeBuy -> HoldN/AView Rating Details
1/31/2017First AnalysisDowngradeOverweight -> Equal WeightN/AView Rating Details
(Data available from 2/24/2016 forward)

Earnings

Aceto (NASDAQ:ACET) Earnings History and Estimates Chart

Earnings by Quarter for Aceto (NASDAQ:ACET)

Aceto (NASDAQ ACET) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2018        
2/1/2018Q2 2018$0.23$0.22$176.50 million$171.20 millionViewListenView Earnings Details
11/2/2017Q1 2018$0.28$0.30$190.58 million$185.26 millionViewN/AView Earnings Details
8/24/2017Q4 2017$0.44$0.27$184.49 million$194.60 millionViewN/AView Earnings Details
5/4/2017Q3 2017$0.44$0.39$195.09 million$190.10 millionViewListenView Earnings Details
2/2/2017Q2 2017$0.32$0.24$136.65 million$125.60 millionViewListenView Earnings Details
11/2/2016Q1 17$0.29$0.28$132.88 million$128.02 millionViewListenView Earnings Details
8/25/2016Q416$0.39$0.35$146.71 million$135.40 millionViewListenView Earnings Details
5/5/2016Q3$0.39$0.42$150.07 million$157.90 millionViewListenView Earnings Details
2/4/2016Q2$0.30$0.36$132.71 million$131.70 millionViewListenView Earnings Details
11/5/2015Q116$0.34$0.37$139.89 million$133.50 millionViewListenView Earnings Details
9/10/2015Q415$0.31$0.48$146.68 million$146.60 millionViewListenView Earnings Details
5/7/2015Q3$0.29$0.34$140.00 million$145.80 millionViewListenView Earnings Details
2/5/2015Q115$0.26$0.28$130.00 million$13.00 millionViewListenView Earnings Details
11/6/2014Q414$0.29$0.23$146.40 million$130.80 millionViewListenView Earnings Details
9/4/2014Q314$0.17$0.21$134.23 million$139.60 millionViewListenView Earnings Details
5/8/2014Q214$0.28$0.19$136.70 million$124.83 millionViewListenView Earnings Details
2/7/2014Q114$0.24$0.24$147.02 million$116.50 millionViewListenView Earnings Details
11/7/2013Q1 2014$0.40$129.26 millionViewN/AView Earnings Details
8/28/2013Q4 2013$0.20$0.19$113.10 million$123.10 millionViewListenView Earnings Details
5/9/2013Q3 2013$0.26$0.34$128.56 million$150.90 millionViewListenView Earnings Details
2/7/2013Q2 2013$0.20$0.17ViewN/AView Earnings Details
11/8/2012Q113$0.19$0.18$110.85 million$111.70 millionViewN/AView Earnings Details
9/6/2012Q4 2012$0.16$0.17ViewN/AView Earnings Details
5/3/2012Q3 2012$0.12$0.18ViewN/AView Earnings Details
2/9/2012Q2 2012$0.07$0.17ViewN/AView Earnings Details
11/3/2011Q1 2012$0.07$0.13ViewN/AView Earnings Details
9/9/2011Q4 2011$0.12$0.13ViewN/AView Earnings Details
5/6/2011Q3 2011$0.17$0.14ViewN/AView Earnings Details
2/4/2011Q2 2011$0.09$0.08ViewN/AView Earnings Details
11/5/2010Q1 2011$0.08$0.11ViewN/AView Earnings Details
9/10/2010Q4 2010$0.10$0.17ViewN/AView Earnings Details
5/7/2010Q3 2010$0.10$0.15ViewN/AView Earnings Details
2/5/2010Q2 2010$0.05($0.05)ViewN/AView Earnings Details
11/6/2009Q1 2010$0.06$0.04ViewN/AView Earnings Details
9/11/2009Q4 2009$0.11$0.04ViewN/AView Earnings Details
5/8/2009Q3 2009$0.12$0.08ViewN/AView Earnings Details
2/6/2009Q2 2009$0.06$0.04ViewN/AView Earnings Details
11/7/2008Q1 2009$0.15$0.18ViewN/AView Earnings Details
9/5/2008Q4 2008$0.19$0.32ViewN/AView Earnings Details
5/9/2008Q3 2008$0.05$0.13ViewN/AView Earnings Details
2/8/2008Q2 2008$0.04$0.04ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Aceto (NASDAQ:ACET) Earnings Estimates

2018 EPS Consensus Estimate: $1.11
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.23$0.32$0.28
Q2 20182$0.22$0.29$0.26
Q3 20182$0.25$0.34$0.30
Q4 20182$0.26$0.31$0.29
Q1 20191$0.29$0.29$0.29
Q2 20191$0.31$0.31$0.31
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Aceto (NASDAQ:ACET) Dividend Information

Next Dividend:3/23/2018
Annual Dividend:$0.26
Dividend Yield:3.45%
Payout Ratio:-162.50% (Trailing 12 Months of Earnings)
25.49% (Based on This Year's Estimates)
22.61% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Aceto (NASDAQ:ACET)

Aceto (NASDAQ:ACET) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/1/2018quarterly$0.070.00595238095238095%3/8/20183/9/20183/23/2018
12/7/2017quarterly$0.072.47%12/15/201712/18/201712/28/2017
8/24/2017quarterly$0.072.29%9/7/20179/8/20179/21/2017
5/4/2017quarterly$0.071.82%6/7/20176/9/20176/23/2017
2/2/2017quarterly$0.071.66%3/8/20173/10/20173/24/2017
12/1/2016quarterly$0.071.3%12/8/201612/12/201612/22/2016
8/25/2016quarterly$0.071.29%9/7/20169/9/20169/20/2016
5/5/2016quarterly$0.061.04%6/7/20166/9/20166/24/2016
2/4/2016quarterly$0.061.18%3/9/20163/11/20163/25/2016
12/3/2015quarterly$0.060.88%12/15/201512/17/201512/28/2015
9/10/2015quarterly$0.060.9%9/17/20159/21/201510/2/2015
5/7/2015quarterly$0.061.12%6/9/20156/11/20156/25/2015
2/5/2015quarterly$0.061.13%3/10/20153/12/20153/26/2015
12/4/2014quarterly$0.061.09%12/11/201412/15/201412/29/2014
9/4/2014quarterly$0.061.12%9/11/20149/15/20149/29/2014
5/8/2014quarterly$0.061.26%6/10/20146/12/20146/27/2014
2/6/2014quarterly$0.061.35%3/11/20143/13/20143/28/2014
12/5/2013quarterly$0.061.08%12/12/201312/16/201312/27/2013
8/28/2013quarterly$0.061.56%9/12/20139/16/20139/27/2013
5/9/2013quarterly$0.062%6/12/20136/14/20136/25/2013
2/7/2013quarterly$0.062.16%3/13/20133/15/20133/26/2013
12/9/2012quarterly$0.062.26%12/13/201212/17/201212/28/2012
(Data available from 1/1/2013 forward)

Insider Trades

Aceto (NASDAQ ACET) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.10%
Institutional Ownership Percentage: 73.64%
Insider Trades by Quarter for Aceto (NASDAQ:ACET)
Institutional Ownership by Quarter for Aceto (NASDAQ:ACET)

Aceto (NASDAQ ACET) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/26/2017Frances P ScallyCAOSell309$10.44$3,225.9618,490View SEC Filing  
9/8/2017Steven RogersSVPSell2,000$10.34$20,680.0038,530View SEC Filing  
9/7/2017Salvatore J Sr Guccione SrInsiderSell218$10.48$2,284.64245,269View SEC Filing  
9/6/2017Albert L EilenderChairmanSell9,530$10.47$99,779.10307,028View SEC Filing  
9/6/2017Salvatore J Sr Guccione SrInsiderSell9,850$10.47$103,129.50241,262View SEC Filing  
9/6/2017Steven RogersSVPSell2,050$10.47$21,463.5040,495View SEC Filing  
9/5/2017Walter J Kaczmarek IIICOOSell2,635$10.57$27,851.9572,817View SEC Filing  
8/2/2017Walter J Kaczmarek IIICOOSell7,083$16.57$117,365.3147,917View SEC Filing  
7/6/2017Albert L EilenderChairmanSell6,500$15.21$98,865.00252,029View SEC Filing  
7/6/2017Frank DebenedittisInsiderSell2,089$15.28$31,919.9276,936View SEC Filing  
7/6/2017Salvatore J Sr Guccione SrCEOSell7,421$15.21$112,873.41190,662View SEC Filing  
7/5/2017Charles John AlaimoInsiderSell2,612$15.48$40,433.7615,017View SEC Filing  
7/5/2017Douglas A RothCFOSell5,075$15.47$78,510.2574,403View SEC Filing  
7/5/2017Steven RogersSVPSell2,285$15.45$35,303.2518,995View SEC Filing  
3/9/2017Frank DebenedittisInsiderSell3,600$14.94$53,784.0082,625View SEC Filing  
1/17/2017Daniel B YaroshDirectorSell891$20.69$18,434.798,179View SEC Filing  
12/9/2016Raymond BartoneInsiderSell5,000$21.54$107,700.0033,452View SEC Filing  
12/8/2016Nicolas I ShackleyInsiderSell2,500$21.27$53,175.0031,476View SEC Filing  
11/30/2016Frank DebenedittisInsiderSell7,040$20.22$142,348.8079,620View SEC Filing  
11/29/2016Satish SrinivasanCOOSell12,917$20.02$258,598.3420,434View SEC Filing  
11/28/2016Albert L EilenderChairmanSell18,500$19.88$367,780.00283,979View SEC Filing  
11/23/2016Steven RogersSVPSell2,400$19.53$46,872.0021,280View SEC Filing  
11/14/2016Hans C NoetzliDirectorSell6,000$18.32$109,920.0085,572View SEC Filing  
9/8/2016Salvatore J Sr Guccione SrInsiderSell260$19.64$5,106.40198,343View SEC Filing  
9/7/2016Charles John AlaimoInsiderSell25$19.43$485.7523,154View SEC Filing  
9/6/2016Albert L EilenderChairmanSell12,936$19.92$257,685.12236,649View SEC Filing  
9/6/2016Frank DebenedittisInsiderSell4,580$19.85$90,913.0076,995View SEC Filing  
9/6/2016Satish SrinivasanCOOSell3,980$19.84$78,963.2026,521View SEC Filing  
9/6/2016Steven RogersSVPSell2,167$20.04$43,426.6820,443View SEC Filing  
9/2/2016Charles John AlaimoInsiderSell2,567$19.85$50,954.9520,255View SEC Filing  
7/19/2016Satish SrinivasanCOOSell595$25.48$15,160.6015,521View SEC Filing  
7/7/2016Frank DebenedittisVPSell3,275$23.34$76,438.5067,495View SEC Filing  
7/6/2016Albert L EilenderChairmanSell7,690$22.53$173,255.70210,199View SEC Filing  
7/6/2016Charles John AlaimoSVPSell3,639$22.41$81,549.9911,755View SEC Filing  
7/6/2016Douglas A RothCFOSell6,770$22.72$153,814.4058,783View SEC Filing  
7/6/2016Salvatore J Sr Guccione SrCEOSell10,945$23.25$254,471.25144,042View SEC Filing  
7/6/2016Satish SrinivasanCOOSell3,250$22.80$74,100.0016,116View SEC Filing  
7/6/2016Steven RogersVPSell3,275$22.50$73,687.5011,943View SEC Filing  
6/7/2016Terry KippleyVPSell2,000$22.50$45,000.0019,249View SEC Filing  
6/7/2016William N BrittonDirectorSell4,200$23.12$97,104.0044,767View SEC Filing  
6/6/2016Frank DebenedittisVPSell6,810$22.63$154,110.3070,770View SEC Filing  
6/6/2016Satish SrinivasanCOOSell3,497$22.69$79,346.9319,366View SEC Filing  
5/31/2016Albert L EilenderChairmanSell9,881$22.21$219,457.01217,889View SEC Filing  
5/26/2016Douglas A RothCFOSell7,000$22.16$155,120.0065,553View SEC Filing  
3/10/2016Raymond BartoneSVPSell3,000$22.40$67,200.0032,109View SEC Filing  
3/8/2016Hans C NoetzliDirectorSell6,500$22.91$148,915.0085,873View SEC Filing  
3/2/2016Frank DebenedittisVPSell3,000$21.98$65,940.0077,580View SEC Filing  
3/1/2016Steven RogersVPSell2,100$21.82$45,822.0015,218View SEC Filing  
2/25/2016Albert L EilenderChairmanSell9,281$21.79$202,232.99237,051View SEC Filing  
2/23/2016Charles John AlaimoSVPSell4,750$21.91$104,072.5020,144View SEC Filing  
2/23/2016Douglas A RothCFOSell17,000$21.52$365,840.0084,553View SEC Filing  
12/9/2015Satish SrinivasanCOOSell3,000$27.02$81,060.0022,863View SEC Filing  
12/9/2015Terry KippleyVPSell1,550$27.06$41,943.0021,249View SEC Filing  
12/8/2015Nicolas I ShackleySVPSell3,000$26.70$80,100.0024,278View SEC Filing  
12/1/2015Charles John AlaimoSVPSell3,000$28.22$84,660.0018,644View SEC Filing  
11/25/2015Hans C. NoetzliDirectorSell3,000$27.52$82,560.0073,881View SEC Filing  
11/24/2015Steven RogersVPSell3,000$27.56$82,680.0017,318View SEC Filing  
10/15/2015Albert L. EilenderChairmanSell8,155$28.90$235,679.50227,770View SEC Filing  
9/10/2015Charles John AlaimoSVPSell1,620$22.14$35,866.8021,560View SEC Filing  
9/10/2015Douglas A. RothCFOSell6,250$22.14$138,375.0079,246View SEC Filing  
9/10/2015Frank DebenedittisVPSell2,553$22.14$56,523.4283,580View SEC Filing  
9/10/2015Salvatore J. Sr Guccione, Sr.CEOSell9,386$22.14$207,806.04154,712View SEC Filing  
7/2/2015Albert L EilenderChairmanSell10,938$24.20$264,699.60View SEC Filing  
7/2/2015Charles John AlaimoSVPSell2,998$24.19$72,521.62View SEC Filing  
7/2/2015Douglas A RothCFOSell5,748$24.19$139,044.12View SEC Filing  
7/2/2015Frank DebenedittisVPSell2,629$24.19$63,595.51View SEC Filing  
7/2/2015Salvatore J Sr Guccione SrCEOSell9,114$24.19$220,467.66View SEC Filing  
7/2/2015Satish SrinivasanCOOSell1,921$24.19$46,468.99View SEC Filing  
6/8/2015Raymond BartoneSVPSell5,000$24.44$122,200.00View SEC Filing  
6/3/2015Frank DebenedittisVPSell4,000$24.41$97,640.00View SEC Filing  
5/27/2015Charles John AlaimoSVPSell2,000$23.19$46,380.00View SEC Filing  
5/12/2015William N BrittonDirectorSell13,000$21.31$277,030.00View SEC Filing  
3/4/2015Douglas A RothCFOSell5,000$20.99$104,950.00View SEC Filing  
3/4/2015Natasha GiordanoDirectorSell2,164$20.92$45,270.88View SEC Filing  
2/12/2015Douglas A RothCFOSell6,000$19.91$119,460.00View SEC Filing  
2/10/2015Charles John AlaimoSVPSell2,000$20.15$40,300.00View SEC Filing  
12/9/2014Frank DebenedittisVPSell3,000$21.25$63,750.00View SEC Filing  
12/5/2014Douglas A RothCFOSell7,000$22.07$154,490.00View SEC Filing  
12/3/2014Terry KippleyVPSell1,950$21.35$41,632.50View SEC Filing  
12/2/2014Terry KippleyVPSell1,797$21.45$38,545.65View SEC Filing  
12/1/2014Satish SrinivasanCOOSell1,430$21.00$30,030.00View SEC Filing  
11/11/2014Charles John AlaimoSVPSell2,250$21.22$47,745.00View SEC Filing  
9/9/2014Douglas A RothCFOSell6,000$21.57$129,420.00View SEC Filing  
9/9/2014Natasha GiordanoDirectorSell1,453$21.94$31,878.82View SEC Filing  
9/9/2014Raymond BartoneSVPSell3,000$21.49$64,470.00View SEC Filing  
9/9/2014Steven RogersVPSell8,335$21.50$179,202.50View SEC Filing  
9/2/2014Albert L EilenderChairmanSell7,144$19.14$136,736.16View SEC Filing  
8/29/2014Hans C NoetzliDirectorSell2,000$18.85$37,700.00View SEC Filing  
8/15/2014Hans C NoetzliDirectorSell2,000$18.63$37,260.00View SEC Filing  
8/4/2014Albert L EilenderChairmanSell4,195$16.71$70,098.45View SEC Filing  
8/1/2014Hans C NoetzliDirectorSell2,000$16.67$33,340.00View SEC Filing  
7/25/2014Albert L EilenderChairmanSell2,450$17.63$43,193.50View SEC Filing  
7/3/2014Hans C NoetzliDirectorSell2,000$17.86$35,720.00View SEC Filing  
7/2/2014Albert L EilenderChairmanSell1,750$18.05$31,587.50View SEC Filing  
6/6/2014Charles John AlaimoSVPSell2,000$17.51$35,020.00View SEC Filing  
6/6/2014Natasha GiordanoDirectorSell1,160$17.28$20,044.80View SEC Filing  
6/6/2014Steven RogersVPSell2,333$17.58$41,014.14View SEC Filing  
6/4/2014Frank DebenedittisVPSell30,000$17.09$512,700.00View SEC Filing  
6/4/2014Nicolas I ShackleyInsiderSell1,000$17.29$17,290.00View SEC Filing  
6/2/2014Douglas A RothCFOSell6,500$17.10$111,150.00View SEC Filing  
6/2/2014Natasha GiordanoDirectorSell1,149$17.43$20,027.07View SEC Filing  
5/23/2014Natasha GiordanoDirectorSell1,128$17.91$20,202.48View SEC Filing  
5/21/2014Natasha GiordanoDirectorSell1,110$17.81$19,769.1012,942View SEC Filing  
3/10/2014Terry KippleyVPSell3,817$19.17$73,171.8915,689View SEC Filing  
2/14/2014Roger Weaving, Jr.SVPSell6,000$18.96$113,760.0051,296View SEC Filing  
11/12/2013Roger Weaving, Jr.SVPSell14,605$19.03$277,933.1545,918View SEC Filing  
9/6/2013Raymond BartoneSVPSell19,000$14.84$281,960.00View SEC Filing  
6/7/2013Roger Weaving JrVPSell4,420$13.02$57,548.40View SEC Filing  
6/6/2013Guillaume Saint-ClairVPSell15,332$13.01$199,469.32View SEC Filing  
6/4/2013Douglas A RothCFOSell30,000$13.31$399,300.00View SEC Filing  
6/4/2013Eis Jan VanDirectorSell9,000$13.39$120,510.00View SEC Filing  
5/24/2013Ronald GoldCOOSell25,000$11.71$292,750.00View SEC Filing  
5/22/2013Frank DebenedittisVPSell8,300$11.86$98,438.00View SEC Filing  
5/21/2013Frank DebenedittisVPSell7,867$12.00$94,404.00View SEC Filing  
5/17/2013Douglas A RothCFOSell20,200$11.31$228,462.00View SEC Filing  
5/17/2013Guillaume Saint-ClairVPSell2,250$11.15$25,087.50View SEC Filing  
5/15/2013Ronald GoldCOOSell55,000$11.23$617,650.00View SEC Filing  
5/14/2013David B RosenVPSell40,000$11.05$442,000.00View SEC Filing  
5/14/2013Roger Weaving JrSVPSell5,600$11.09$62,104.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Aceto (NASDAQ ACET) News Headlines

Source:
DateHeadline
Head to Head Survey: Aceto (ACET) & Pernix Therapeutics (PTX)Head to Head Survey: Aceto (ACET) & Pernix Therapeutics (PTX)
www.americanbankingnews.com - February 19 at 5:10 AM
Aceto (ACET) Rating Reiterated by Canaccord GenuityAceto (ACET) Rating Reiterated by Canaccord Genuity
www.americanbankingnews.com - February 16 at 4:20 PM
ACETO Appoints Edward J. Borkowski Chief Financial OfficerACETO Appoints Edward J. Borkowski Chief Financial Officer
finance.yahoo.com - February 16 at 9:16 AM
Stock Traders Purchase Large Volume of Aceto Put Options (ACET)Stock Traders Purchase Large Volume of Aceto Put Options (ACET)
www.americanbankingnews.com - February 15 at 6:38 AM
ACETO Subsidiary, Rising Pharmaceuticals, Launches Atenolol Tablets, 25mg, 50mg and 100mgACETO Subsidiary, Rising Pharmaceuticals, Launches Atenolol Tablets, 25mg, 50mg and 100mg
finance.yahoo.com - February 8 at 9:02 AM
Aceto (ACET) Cut to Strong Sell at Zacks Investment ResearchAceto (ACET) Cut to Strong Sell at Zacks Investment Research
www.americanbankingnews.com - February 6 at 4:34 PM
First Analysis Comments on Aceto Co.s FY2018 Earnings (ACET)First Analysis Comments on Aceto Co.'s FY2018 Earnings (ACET)
www.americanbankingnews.com - February 6 at 10:48 AM
Free Research Report as Air Products’ Sales Surged 18%; Non-GAAP Earnings 23%Free Research Report as Air Products’ Sales Surged 18%; Non-GAAP Earnings 23%
finance.yahoo.com - February 6 at 9:00 AM
Aceto (ACET) Receives Buy Rating from Canaccord GenuityAceto (ACET) Receives Buy Rating from Canaccord Genuity
www.americanbankingnews.com - February 5 at 6:46 AM
Why Aceto Corporation's Shares Plunged 17% TodayWhy Aceto Corporation's Shares Plunged 17% Today
finance.yahoo.com - February 2 at 4:44 PM
Why Aceto Corporations Shares Plunged 17% TodayWhy Aceto Corporation's Shares Plunged 17% Today
www.fool.com - February 2 at 12:51 PM
ACETO Reports Fiscal 2018 Second Quarter ResultsACETO Reports Fiscal 2018 Second Quarter Results
finance.yahoo.com - February 2 at 9:01 AM
Aceto (ACET) Releases FY18 Earnings GuidanceAceto (ACET) Releases FY18 Earnings Guidance
www.americanbankingnews.com - February 1 at 9:14 PM
Aceto (ACET) Posts  Earnings Results, Misses Expectations By $0.01 EPSAceto (ACET) Posts Earnings Results, Misses Expectations By $0.01 EPS
www.americanbankingnews.com - February 1 at 9:14 PM
Aceto Co. to Issue Quarterly Dividend of $0.07 (ACET)Aceto Co. to Issue Quarterly Dividend of $0.07 (ACET)
www.americanbankingnews.com - February 1 at 3:16 PM
Aceto Corporation declares $0.065 dividendAceto Corporation declares $0.065 dividend
seekingalpha.com - February 1 at 2:37 PM
Why Aceto Corporation (NASDAQ:ACET) Could Be A BuyWhy Aceto Corporation (NASDAQ:ACET) Could Be A Buy
finance.yahoo.com - January 31 at 4:37 PM
Aceto Co. (ACET) Given Average Rating of "Hold" by AnalystsAceto Co. (ACET) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - January 28 at 1:34 AM
Aceto (ACET) Scheduled to Post Earnings on ThursdayAceto (ACET) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - January 25 at 1:26 AM
Nova Molecular Technologies a Major Player in the Acetonitrile MarketNova Molecular Technologies a Major Player in the Acetonitrile Market
www.prnewswire.com - January 22 at 7:25 PM
Analyzing Aceto (ACET) and Celgene (CELG)Analyzing Aceto (ACET) and Celgene (CELG)
www.americanbankingnews.com - January 19 at 7:37 AM
ACETO Corporation Schedules Second Quarter Fiscal 2018 Financial Results News Release and Conference CallACETO Corporation Schedules Second Quarter Fiscal 2018 Financial Results News Release and Conference Call
finance.yahoo.com - January 18 at 7:14 PM
Cellectar Biosciences (CLRB) versus Aceto (ACET) Head-To-Head ReviewCellectar Biosciences (CLRB) versus Aceto (ACET) Head-To-Head Review
www.americanbankingnews.com - January 16 at 1:10 AM
Aceto (ACET) vs. Celsius (CELH) Financial ContrastAceto (ACET) vs. Celsius (CELH) Financial Contrast
www.americanbankingnews.com - January 5 at 5:04 AM
Aceto Corporation’s (NASDAQ:ACET) Earnings Declined -75.06%, But How Did It Fare Against The Industry?Aceto Corporation’s (NASDAQ:ACET) Earnings Declined -75.06%, But How Did It Fare Against The Industry?
finance.yahoo.com - January 3 at 3:50 PM
Aceto Co. (ACET) Receives Average Recommendation of "Hold" from AnalystsAceto Co. (ACET) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - January 3 at 1:58 AM
ACETO Subsidiary, Rising Pharmaceuticals, Launches Efavirenz Capsules, 50mg and 200mgACETO Subsidiary, Rising Pharmaceuticals, Launches Efavirenz Capsules, 50mg and 200mg
finance.yahoo.com - January 2 at 4:15 PM
Investors’ Favorite Healthcare Dividend StocksInvestors’ Favorite Healthcare Dividend Stocks
finance.yahoo.com - December 29 at 9:33 AM
Is Aceto Corporation (NASDAQ:ACET) A Financially Sound Company?Is Aceto Corporation (NASDAQ:ACET) A Financially Sound Company?
finance.yahoo.com - December 26 at 4:26 PM
Aceto Corp. breached its 50 day moving average in a Bearish Manner : ACET-US : December 22, 2017Aceto Corp. breached its 50 day moving average in a Bearish Manner : ACET-US : December 22, 2017
finance.yahoo.com - December 22 at 11:22 AM
Aceto Corp. : ACET-US: Dividend Analysis : December 18th, 2017 (record date) : By the numbers : December 18, 2017Aceto Corp. : ACET-US: Dividend Analysis : December 18th, 2017 (record date) : By the numbers : December 18, 2017
finance.yahoo.com - December 18 at 3:48 PM
Aceto (ACET) Downgraded to "Strong Sell" at BidaskClubAceto (ACET) Downgraded to "Strong Sell" at BidaskClub
www.americanbankingnews.com - December 16 at 3:36 PM
Aceto Corp. breached its 50 day moving average in a Bullish Manner : ACET-US : December 11, 2017Aceto Corp. breached its 50 day moving average in a Bullish Manner : ACET-US : December 11, 2017
finance.yahoo.com - December 11 at 11:50 AM
Aceto Corporation (ACET) Given Average Recommendation of "Hold" by BrokeragesAceto Corporation (ACET) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - December 9 at 1:48 AM
Analyzing Lannett (LCI) & Aceto (ACET)Analyzing Lannett (LCI) & Aceto (ACET)
www.americanbankingnews.com - December 7 at 9:38 PM
Aceto Corporation (ACET) Announces Quarterly Dividend of $0.07Aceto Corporation (ACET) Announces Quarterly Dividend of $0.07
www.americanbankingnews.com - December 7 at 4:05 PM
The global acetone market is forecasted to grow at a CAGR of 3.34% during the period 2017-2021The global acetone market is forecasted to grow at a CAGR of 3.34% during the period 2017-2021
www.prnewswire.com - December 4 at 9:21 PM
Acetonitrile Market Worth 277.1 Million USD by 2022Acetonitrile Market Worth 277.1 Million USD by 2022
www.prnewswire.com - December 4 at 5:28 AM
Aceto Corp. – Value Analysis (NASDAQ:ACET) : November 29, 2017Aceto Corp. – Value Analysis (NASDAQ:ACET) : November 29, 2017
finance.yahoo.com - November 29 at 3:51 PM
Aceto Corporation (ACET) Receives Consensus Rating of "Hold" from BrokeragesAceto Corporation (ACET) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - November 14 at 1:50 AM
Zacks Investment Research Lowers Aceto Corporation (ACET) to Strong SellZacks Investment Research Lowers Aceto Corporation (ACET) to Strong Sell
www.americanbankingnews.com - November 9 at 4:56 PM
Q3 2018 EPS Estimates for Aceto Corporation (ACET) Cut by First AnalysisQ3 2018 EPS Estimates for Aceto Corporation (ACET) Cut by First Analysis
www.americanbankingnews.com - November 9 at 1:50 PM
Relative Strength Alert For AcetoRelative Strength Alert For Aceto
www.thestreet.com - November 8 at 10:20 PM
Analysts Offer Predictions for Aceto Corporations Q2 2018 Earnings (ACET)Analysts Offer Predictions for Aceto Corporation's Q2 2018 Earnings (ACET)
www.americanbankingnews.com - November 8 at 6:24 PM
ETFs with exposure to Aceto Corp. : November 7, 2017ETFs with exposure to Aceto Corp. : November 7, 2017
finance.yahoo.com - November 7 at 4:52 PM
Edited Transcript of ACET earnings conference call or presentation 3-Nov-17 1:00pm GMTEdited Transcript of ACET earnings conference call or presentation 3-Nov-17 1:00pm GMT
finance.yahoo.com - November 4 at 1:23 AM
Aceto Corporation 2018 Q1 - Results - Earnings Call SlidesAceto Corporation 2018 Q1 - Results - Earnings Call Slides
seekingalpha.com - November 3 at 3:16 PM
Aceto posts 1Q profitAceto posts 1Q profit
finance.yahoo.com - November 3 at 10:20 AM
Aceto Corporation to Host Earnings CallAceto Corporation to Host Earnings Call
finance.yahoo.com - November 3 at 10:20 AM
Aceto Corporation (ACET) Posts  Earnings Results, Beats Estimates By $0.01 EPSAceto Corporation (ACET) Posts Earnings Results, Beats Estimates By $0.01 EPS
www.americanbankingnews.com - November 2 at 9:28 PM

SEC Filings

Aceto (NASDAQ:ACET) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Aceto (NASDAQ:ACET) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Aceto (NASDAQ ACET) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.